Eli Lilly (LLY) is a pharmaceutical company that focuses on cardiometabolic health, neuroscience, oncology, and immunology.

Eli Lilly LLY and AbbVie ABBV are U.S.-based pharmaceutical powerhouses with blockbuster drug portfolios, robust pipelines, ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

Eli Lilly's stock recently took a hit, leaving investors scrambling like pharmacists out of espresso. The company’s ...

The deal, announced June 17, includes a cash offer of $10.50 per share for all outstanding Verve stock. Lilly may also pay as ...

Eli Lilly and Company (NYSE:LLY) is one of Best Dividend Stocks to Buy for Dependable Dividend Growth. According to Adam ...

"Under the circumstances—including the lack of evidence regarding harm that Nike will suffer, the brevity of the stay, and ...

Explore the future of the pharmaceutical industry with this comprehensive report. Delve into key trends via regulatory, clinical, and market analyses. Essential for investors, new entrants, and pharma ...

The deal, which could be worth up to $870 million overall, will give Lilly access to a delivery technology that may help ...